Title : Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells.

Pub. Date : 2017 Aug 1

PMID : 28454878






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells. salinomycin AKT serine/threonine kinase 1 Homo sapiens
2 A combination of erlotinib and salinomycin resulted in synergistic enhancement of cytotoxicity and cell growth inhibition in NSCLC cells, accompanied with reduced protein levels of phospho-AKT(Ser473), phospho-AKT(Thr308), and TS. salinomycin AKT serine/threonine kinase 1 Homo sapiens
3 A combination of erlotinib and salinomycin resulted in synergistic enhancement of cytotoxicity and cell growth inhibition in NSCLC cells, accompanied with reduced protein levels of phospho-AKT(Ser473), phospho-AKT(Thr308), and TS. salinomycin AKT serine/threonine kinase 1 Homo sapiens
4 Overexpression of a constitutive active AKT (AKT-CA) or Flag-TS expression vector reversed the salinomycin and erlotinib-induced synergistic cytotoxicity. salinomycin AKT serine/threonine kinase 1 Homo sapiens
5 Overexpression of a constitutive active AKT (AKT-CA) or Flag-TS expression vector reversed the salinomycin and erlotinib-induced synergistic cytotoxicity. salinomycin AKT serine/threonine kinase 1 Homo sapiens
6 Our findings suggested that the down-regulation of AKT-mediated TS expression by salinomycin enhanced the erlotinib-induced cytotoxicity in NSCLC cells. salinomycin AKT serine/threonine kinase 1 Homo sapiens